Biotech

SmallCaps DailyDecember 25, 2018
520

Oncology Venture receives positive feed-back from the FDA on approval pathway for LiPlaCis and DRP in the US Stockholm Stock Exchange:OV

[ad_1] Company NewsOncology Venture receives positive feed-back from the FDA on approval pathway for LiPlaCis and DRP in the US…
Read More »
SmallCaps DailyDecember 25, 2018
1,054

Lexicon pain drug advances after clearing early clinical test

[ad_1] A part 1a trial of Lexicon Pharmaceuticals’ LX9211 has met its main aims. The examine discovered the AAK1 inhibitor…
Read More »
SmallCaps DailyDecember 24, 2018
803

Roivant strikes broad pipeline pact with Daiichi

[ad_1] Roivant has secured an choice to license a stream of medication from Daiichi Sankyo. The deal is the primary…
Read More »
SmallCaps DailyDecember 24, 2018
856

International Isotopes Inc. (OTCBB:INIS) is Attracting Smart Money

[ad_1] In a simply printed Form 13, filed with the US Securities and Exchange Commission (SEC), International Isotopes Inc. (OTCBB:INIS) reported…
Read More »
SmallCaps DailyDecember 24, 2018
612

Communique from EGM in Oncology Venture A/S Stockholm Stock Exchange:OV

[ad_1] Company Announcement Communique from EGM in Oncology Venture A/S Hoersholm, Denmark, December 18, 2018 – at this time,…
Read More »
SmallCaps DailyDecember 23, 2018
628

Chugai preps filings for IL-6 drug in rare disease, chasing Soliris

[ad_1] Chugai has the optimistic part 3 knowledge it must file IL-6-targeting antibody satralizumab for approval in neuromyelitis optica spectrum…
Read More »
SmallCaps DailyDecember 23, 2018
742

Here’s Who Just Picked Up Photomedex Inc (NASDAQ:PHMD) Shares

[ad_1] In a simply revealed Form 13, filed with the US Securities and Exchange Commission (SEC), Photomedex Inc (NASDAQ:PHMD) reported…
Read More »
SmallCaps DailyDecember 22, 2018
939

DBV pulls peanut allergy filing after FDA faults data details

[ad_1] DBV Technologies has withdrawn the filing for FDA approval of its peanut allergy remedy. The French biotech pulled the…
Read More »
SmallCaps DailyDecember 22, 2018
626

Cara Therapeutics Continues to Climb (NASDAQ:CARA)

[ad_1] We suppose Cara Therapeutics (NASDAQ: CARA), a boutique “clinical stage” biotech/biopharma firm which develops novel compounds (together with hashish…
Read More »
SmallCaps DailyDecember 22, 2018
894

The Right Way to Address Prescription Drug Costs

[ad_1] Writing for STAT News, BIO’s President and CEO Jim Greenwood teamed up with Bay City Capital’s David Beier to…
Read More »

No items found.